![Matthew Bartholomae](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Matthew Bartholomae is Secretary & General Counsel at Cartesian Therapeutics, Inc. since 2023.
Formerly, Secretary & General Counsel at Selecta Biosciences, Inc. from 2020 to 2023, and Counsel at Minerva Neurosciences, Inc. from 2016 to 2018.
Education includes undergraduate studies at Boston College and graduate studies at the University of New Hampshire School of Law.
Postes actifs de Matthew Bartholomae
| Sociétés | Poste | Début |
|---|
Anciens postes connus de Matthew Bartholomae
| Sociétés | Poste | Fin |
|---|---|---|
| CARTESIAN THERAPEUTICS, INC. | Conseiller Juridique Général | 01/11/2023 |
| MINERVA NEUROSCIENCES, INC. | Corporate Officer/Principal | 01/01/2018 |
Formation de Matthew Bartholomae
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
16
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Develops targeted immunotherapies and vaccines to treat and prevent diseases | Health Technology |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Minerva Neurosciences, Inc.
 Minerva Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes drugs to treat patients suffering from central nervous system diseases | Health Technology |
University of New Hampshire School of Law
 University of New Hampshire School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Choisissez Zonebourse 
